에 대한 최신 뉴스 Iris Energy (NASDAQ:IREN) 주식

Iris Energy

Iris Energy Ltd is a Bitcoin mining company. It builds, owns, and operates data centers and electrical infrastructure for the mining of Bitcoin powered by renewable energy. The company's mining operations generate revenue by earning Bitcoin through a combination of block rewards and transaction fees from the operation of its specialized computers called Application-specific Integrated Circuits and exchanging these Bitcoin for currencies such as USD or CAD on a daily basis.

Equities

News

Markets

$BTC

AFRM

CRWD

IREN

NVDA

TSLA

수요일 미국 주요 지수는 다우존스 산업평균지수가 0.4% 하락한 41,091.42, S&amp;P 500 지수가 0.6% 하락한 5,592.18로 하락 마감했다. 나스닥지수는 1.1% 하락한 17,556.03에 마감되었다.
이들은 하루 동안 소매 거래자와 투자자들의 주목을 받은 주요 종목들이다:
엔비디아(NASDAQ:NVDA)

화요일 주목받은 5주식: 엔비디아, 어펌, 크라우드스트라이크, 아이리스 에너지, 테슬라

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Earnings

After-Hours Center

Movers

아이리스 에너지(NASDAQ:IREN)는 수요일 시장 마감 후에 회계연도 재무 결과를 발표했다. 이 발표로 주가는 시간외 거래에서 5% 이상 상승했다. 다음은 보고서의 주요 수치들이다.

아이리스 에너지의 주식이 2024 회계연도 실적 발표 후 시간외 거래에서 5% 이상 상승

Iris Energy Ltd

Iren SpA

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the communication services sector.
<h3 class="wp-block-heading">Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>)</h3>
<ul>
<li>Dividend Yield: 6.04%</li>
<li>B of A Securities analyst David Barden maintained a Neutral rating and raised the price target from $41 to $45 on Sept. 26. This analyst has an accuracy rate of 65%.</li>
<li>Citigroup analyst Michael Rollins maintained a Buy rating and increased the price target from $47 to $49 on Sept. 25. This analyst has an accuracy rate of 77%</li>
<li>Recent News: Vay collaborated with Verizon Communications to integrate Verizon 5G connectivity into Vay's fleet of teleoperated electric vehicles.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent093024&amp;t=be2bearmibe3na1"> latest VZ news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent093024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="916" height="858" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30045916/image-230.png" alt="" class="wp-image-571915" style="width:697px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30045916/image-230.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30045916/image-230-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30045916/image-230-768x719.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure>
<h3 class="wp-block-heading">AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>)</h3>
<ul>
<li>Dividend Yield: 5.07%</li>
<li>Tigress Financial analyst Ivan Feinseth maintained a Buy rating and raised the price target from $29 to $30 on Sept. 27. This analyst has an accuracy rate of 73%.</li>
<li>Citigroup analyst Michael Rollins maintained a Buy rating and increased the price target from $21 to $24 on Sept. 11. This analyst has an accuracy rate of 77%</li>
<li>Recent News: The company's board of directors declared a quarterly dividend of $27.75 cents per share on common shares.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent093024&amp;t=be2bearmibe3na1">latest T news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent093024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="918" height="852" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30045930/image-231.png" alt="" class="wp-image-571917" style="width:683px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30045930/image-231.png 918w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30045930/image-231-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30045930/image-231-768x713.png 768w" sizes="(max-width: 918px) 100vw, 918px" /></a></figure>
<h3 class="wp-block-heading">The Interpublic Group of Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPG#NYSE">IPG</a>)</h3>
<ul>
<li>Dividend Yield: 4.17%</li>
<li>Barclays analyst Julien Roch maintained an Equal-Weight rating and cut the price target from $35 to $34 on July 25. This analyst has an accuracy rate of 62%.</li>
<li>Morgan Stanley analyst Benjamin Swinburne downgraded the stock from Equal-Weight to Underweight and cut the price target from $34 to $28 on July 22. This analyst has an accuracy rate of 76%.</li>
<li>Recent News: On Sept. 18, Interpublic named Alex Hesz as Chief Strategy Officer.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent093024&amp;t=be2bearmibe3na1">trend in IPG stock.</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent093024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="918" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30050005/image-232.png" alt="" class="wp-image-571918" style="width:661px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30050005/image-232.png 918w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30050005/image-232-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30050005/image-232-768x704.png 768w" sizes="(max-width: 918px) 100vw, 918px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/41075978/top-4-materials-stocks-that-may-implode-in-q3">Top 4 Materials Stocks That May Implode In Q3</a></li>
</ul>

Dividends

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

Wall Street's Most Accurate Analysts Give Their Take On 3 Tech And Telecom Stocks Delivering High-Dividend Yields

U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.1% on Monday.
Shares of Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) fell sharply in today's pre-market trading after the company <a href="https://www.benzinga.com/quote/STLA/news">updated its 2024 guidance.</a>
Stellantis said it now expects FY24 operating margin of 5.5%-7.0%, down from its prior double-digit growth expectations.
Stellantis shares dipped 11.6% to $14.20 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Bitdeer Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) shares dipped 13% to $7.34 in pre-market trading after gaining over 5% on Friday.</li>
<li>Corvus Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVS#NASDAQ">CRVS</a>) declined 11.6% to $4.55 in today's pre-market trading.</li>
<li>Venus Concept Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) shares declined 10.4% to $0.62 in pre-market trading. Venus Concept shares jumped around 20% on Friday after the company announced a $15 million debt-to-equity exchange transaction.</li>
<li>Applied Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) shares fell 8.3% to $7.51 in pre-market trading.</li>
<li>Cipher Mining Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) shares fell 6.1% to $3.86 in pre-market trading. Northland Capital Markets, last week, initiated coverage on the stock with an Outperform rating and announced a $6 price target.</li>
<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares declined 6.1% to $165.51 in pre-market trading amid a decline in Bitcoin prices.</li>
<li>Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) shares fell 5.2% to $12.40 in pre-market trading amid a decline in Bitcoin prices.</li>
<li>Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) shares slipped 5.2% to $3.45 in pre-market trading amid a decline in Bitcoin prices.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/41075978/top-4-materials-stocks-that-may-implode-in-q3">Top 4 Materials Stocks That May Implode In Q3</a></li>
</ul>

APLD

BTBT

BTDR

CIFR

CRVS

MSTR

STLA

VERO

Stellantis, MicroStrategy, Bit Digital And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Goldman Sachs analyst Alexander Blostein maintains Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) with a Buy and raises the price target from $145 to $160.

ARES

Goldman Sachs Maintains Buy on Ares Management, Raises Price Target to $160

CVS Health Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) is set to face renewed pressure as hedge fund Glenview Capital Management, led by founder Larry Robbins, plans to meet top executives, including CEO Karen Lynch, to discuss operational improvements.
The meeting with Glenview comes as part of Robbins&#8217; broader strategy to push for change, the Wall Street Journal reports.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/08/40437498/pharmacy-chains-like-cvs-health-walgreens-boots-alliance-confront-shifting-consumer-habits-and-pro" rel="noreferrer noopener">Pharmacy Chains Like CVS Health, Walgreens Boots Alliance Confront Shifting Consumer Habits And Profit Pressures</a>.
Robbins, who has built a substantial $700 million position in CVS, sees potential for the company to revitalize its struggling business without resorting to a breakup.
Robbins is expected to propose cost-cutting and restructuring strategies but will not push for a breakup of CVS. Another hedge fund has also built a notable position in the company, hinting at further pressure from investors.
CVS, one of the largest healthcare companies in the U.S., has seen its stock tumble 24% year-to-date amid multiple earnings downgrades.
In the second quarter, the pharmacy chain reported adjusted EPS of&nbsp;$1.83&nbsp;decreased from&nbsp;$2.21&nbsp;in the prior year, beating the consensus of $1.73. The fall is primarily due to a decline in the Health Care Benefits segment&#8217;s operating results, which reflect continued utilization pressure and the unfavorable impact of the company&#8217;s Medicare Advantage star ratings for the 2024 payment year within <a target="_blank" href="https://www.benzinga.com/news/earnings/24/08/40220306/cvs-health-reports-mixed-q2-earnings-lowers-2024-outlook-reshuffles-segment-management" rel="noreferrer noopener">the Medicare product line</a>.
CVS Health revised its adjusted EPS guidance to $6.40-$6.65&nbsp;from at least&nbsp;$7.00 versus the consensus of $6.98, reflecting continued pressure in the Health Care Benefits segment.
The Wall Street report <a target="_blank" href="https://www.wsj.com/health/healthcare/glenview-capital-plans-push-for-changes-at-cvs-5df8aa8a?mod=latest_headlines" rel="noreferrer noopener">adds</a> that CVS had heavily invested in attracting seniors to its Aetna Medicare plans, but the move backfired, squeezing margins. The company is now revising its Medicare approach for 2025 to address these issues.
CVS Health decided to make leadership changes based on the current performance and outlook for the Health Care Benefits segment.&nbsp;
Brian Kane&nbsp;quit, and Karen Lynch,&nbsp;the CEO, assumed direct leadership of the Health Care Benefits segment.
Karen and Tom Cowhey, CVS Health&#8217;s CFO, oversee the business&#8217;s day-to-day management.
Recently, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health&#8217;s Caremark,&nbsp;Cigna Corp&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) Express Scripts, and&nbsp;UnitedHealth Group Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) Optum—for allegedly engaging in unfair and anti-competitive practices that have inflated the list&nbsp;<a target="_blank" href="https://www.benzinga.com/news/large-cap/24/09/40964870/us-federal-trade-commission-sues-cvs-health-cigna-unitedhealths-pharmacy-benefit-managers-for-infl" rel="noreferrer noopener">price of insulin medications</a>.
The FTC has also highlighted significant concerns regarding consolidating pharmacies and health insurance companies, focusing on the influence of a few dominant PBMs <a target="_blank" href="https://www.benzinga.com/government/24/07/39695378/ftc-investigation-uncovers-anti-competitive-practices-by-handful-of-pharmacy-benefit-managers-includ" rel="noreferrer noopener">on prescription drug prices</a>.
Price Action: CVS stock is up 3.27% at $63.39 during the premarket session at last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/41075259/udemy-downgrade-analyst-warns-of-negative-riskreward-profile-while-demand-is-weak" target="_blank" rel="noreferrer noopener">Udemy Downgrade: Analyst Warns Of Negative Risk/Reward Profile While Demand Is Weak</a>.</li>
</ul>
Photo: Around the World Photos via Shutterstock

Large Cap

Health Care

Media

General

CVS Health in Focus as Activist Investor Prepares for High-Level Talks

Offerings

ASST

Asset Entities Announces At-The-Market Offering Of Up To $1.79M In Class B Common Stock

Cantor Fitzgerald analyst Louise Chen reiterates Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) with a Overweight and maintains $215 price target.

Reiteration

Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target

Biotech

WINT

Windtree Announces Worsening Heart Failure Reported As A Serious Adverse Event Occurred Less Frequently In The Istaroxime Group Compared To Placebo 5.3% Versus 18.2%, Respectively.

NIO: 15% &#x7C; <a href="https://www.benzinga.com//node/41089541">Nio shares are trading higher after investors agreed to invest an aggregate of 3.3 billion yuan in its Nio China subsidiary while the company agreed to invest 10 billion yuan.</a>
&nbsp;
PRME: 33% &#x7C; <a href="https://www.benzinga.com//node/41088636">Prime Medicine Enters Strategic Research Collaboration And License Agreement With Bristol Myers Squibb; Prime Medicine To Receive $110M Upfront, With Potential For More Than $3.5B In Milestones</a>
&nbsp;
BL: 4% &#x7C; <a href="https://www.benzinga.com//node/41089664">BlackLine shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $60 to $70.</a>

PRME

Market-Moving News for September 30th

Billionaire investor and investment guru <a href="https://www.benzinga.com/topic/warren-buffett">Warren Buffett </a>once shared the thumb rule he uses when to give up on a stock and in the process explained why investors are better off than business tycoons such as Andrew Carnegie or John Rockefeller.
What Happened: &#8220;I love it when the things we buy go down,&#8221; <a href="https://www.youtube.com/watch?v=cSU3y0N60XU">said</a> Buffett in a 2014 Fortune Magazine interview. He said he would get &#8220;euphoric when the stocks are down because he can buy more of something he owned. On the other hand, with their stocks, people think the stock knows more than they do, he said.
&#8220;When the stock goes down, they say the stock is telling them something&#8230; and what it&#8217;s telling me is I can get more for my money,&#8221; the Berkshire Hathaway CEO said. But they take it as a kind of referendum on themselves and make it as a &#8220;me versus stock&#8221; and say if they get back what they paid, they are going to sell the stock irrespective of what they paid, he said.
&#8220;Stock doesn&#8217;t care what you paid; you have to remember the stock doesn&#8217;t even care that you own it; you are nothing to the stock; that stock is everything to you,&#8221; Buffett said.
The only question with every stock, every day is to look into &#8220;Can I get more for my money someplace else,&#8221; he said, adding that investors get a chance to be in thousands and thousands of great businesses and their prices change all the time and so do their relative valuation.
See Also: <a href="https://www.benzinga.com/money/best-value-stocks">Best Value Stocks</a>
Since an investor can make the exchange at a very low cost these days, either with low commissions or nothing, they can always shift from one business to another, Buffett said. Investors have an advantage over Carnegie, who was in the steel business or Rockefeller who was in the oil business, he said. The billionaire said these businessmen couldn&#8217;t immediately shift to something like retailing or rearrange their business empire as an investor can with the portfolio they owned. The portfolio can be rearranged at a moment&#8217;s notice with practically no cost, he said, adding that this is a huge advantage.
&#8220;There is nothing about the price action of the stock that tells you whether you should keep owning; what tells you whether you should keep owning it is what you expect the company to do in the future versus the price at which it&#8217;s selling now compared to the other opportunities of businesses you think you know equally well and make that same comparison and that&#8217;s all there is to owning stocks,&#8221; Buffett said.
Why It&#8217;s Important: Buffett swears by an investment philosophy called value investing, which advocates picking stocks that appear to be trading for less than their intrinsic or book value. He has been very successful with the strategy and the success of Berkshire is a testament to it. The company, which owns holding companies primarily in the insurance and transportation businesses, as well as portfolio stocks, is now the eighth most valued global corporation, standing head-on-head with tech stocks.
Amid the current economic uncertainty, Buffett has shown a preference for accumulating a huge cash pile. At the end of the second quarter, the company <a href="https://www.benzinga.com/markets/equities/24/09/40917216/elon-musk-says-warren-buffett-is-positioning-for-kamala-harris-win-with-his-277b-cash-pile-as-pr">had a massive cash pile of $277 billion. </a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/41018183/did-aping-warren-buffett-and-hedge-fund-managers-bring-success-to-this-ai-powered-etf-that-launc">Did Aping Warren Buffett And Hedge Fund Managers Bring Success To This AI-Powered ETF That Launched Last Week?</a></li>
</ul>
Photo: mark reinstein/Shutterstock.com

Education

Warren Buffet Tells Investors To Give Up On 'Me Vs. Stock' Approach: 'What Tells You Whether You Should Keep Owning A Stock Is…'

Wedbush analyst David Nierengarten reiterates Inozyme Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INZY#NASDAQ">INZY</a>) with a Outperform and maintains $15 price target.

INZY

Wedbush Reiterates Outperform on Inozyme Pharma, Maintains $15 Price Target

BIOR

Biora Therapeutics' Award-Winning Abstract To Be Presented At American College Of Gastroenterology Annual Meeting

ISO Certification paves the way to OEM relationships which could include direct and indirect sales to global car makers such as Rivian, Tesla, Ford, General Motors, Hyundai, Honda, Stellantis, Nissan, and Toyota. &nbsp;
West Seneca, New York, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Worksport Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) ("Worksport" or the "Company"), a U.S.-based manufacturer and innovator of hybrid and clean energy solutions for the light truck, overlanding, and global consumer goods sectors is thrilled to announce that it is progressing towards achievement of ISO 9000 certification at its state-of-the-art West Seneca, NY factory anticipated by early-mid 2025. This certification reflects Worksport's commitment to quality manufacturing and is expected to support potential growth in key future markets including government contracts, Original Equipment Manufacturers ("OEM") relationships and larger distribution networks. OEM relationships may lead to future direct and indirect sales opportunities to domestic car brands such as Rivian, Tesla, Ford, General Motors, Hyundai, Honda, Stellantis, Nissan, and Toyota.

WKSP

Worksport Provides Progress Update On ISO 9000 Certification,  Paving The Way To OEM Relationships Which Could Include Direct And Indirect Sales To Global Car Makers Such As Rivian, Tesla, Ford, General Motors, Hyundai, Honda, Stellantis, Nissan, And Toyota

Istaroxime treatment significantly improved systolic blood pressure as well as cardiac output and renal function without increasing heart rate or clinically significant arrythmias
NYHA heart failure classification was improved up to 72 hours with a serious adverse event profile generally similar to placebo
WARRINGTON, Pa., Sept. 30, 2024 (GLOBE NEWSWIRE) -- &nbsp;Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced positive topline clinical results for its Phase 2b SEISMiC Extension Study of istaroxime in heart failure patients in early cardiogenic shock.
Early cardiogenic shock is caused by a failing heart and is characterized by low blood pressure, leaving the patient at risk of developing inadequate blood flow to vital organs leading to high morbidity and mortality. Istaroxime is a novel first-in-class investigational therapy that is intended to improve systolic contraction and diastolic relaxation of the heart while also increasing blood pressure and maintaining renal function with a generally favorable safety profile. Istaroxime has been studied in four positive Phase 2 trials enrolling patients with acute heart failure and early cardiogenic shock due to heart failure.

Windtree Announces Positive Phase 2b Topline Clinical Results With Istaroxime Significantly Improving Cardiac Function And Blood Pressure In Heart Failure Patients In Early Cardiogenic Shock; The Study Met Its Primary Endpoint In Significantly Improving Systolic Blood Pressure Over Six Hours, With The Combined Part A And Part B Seismic Istaroxime Group Performing Significantly Better Compared To The Placebo Group

WIIM

EMKR

Emcore shares are trading higher after Mobix Labs submitted an all-cash offer to acquire the company for $3.80 per share.

GRRR

Gorilla Technology Group H1 2024 Revenue $20.67M Vs $6.43M YoY

In Partnership with Perfect Corp., Starboard's AI-Powered SkInsight Experience Delivers Personalized Skincare Solutions
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.perfectcorp.com%2F&amp;esheet=54128691&amp;newsitemid=20240930181292&amp;lan=en-US&amp;anchor=Perfect+Corp&amp;index=1&amp;md5=ebc62a234573f444562e05415b876be1">Perfect Corp</a>.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PERF#NYSE">PERF</a>), a global leader in augmented reality (AR) and artificial intelligence (AI) beauty and fashion tech, today announced a collaboration with Starboard Group,the world's leading vacation retail curator. Starboard is continuing to pave the way for innovation as it rolls out its SkInsight experience, a cutting-edge interactive AI skin analysis, onboard 30 more ships this month. Developed in partnership with Perfect Corp., a pioneer in ‘Beautiful AI', the SkInsight digital experience delivers detailed skin assessments to guests in seconds, along with uniquely personalized skincare regimens featuring products available for purchase onboard. Starboard debuted the SkInsight experience on Carnival Jubilee in December 2023 and will now offer the AI solution at retail stores on ships across Royal Caribbean International, Carnival Cruise Line, Virgin Voyages and TUI Mein Schiff fleets.

PERF

Perfect Corp.  Announces A Collaboration With Starboard Group, Expanding Its Exclusive Skinsight Ai Skin Analysis Across Global Fleet, Redefining Onboard Beauty Retail

The <a href="https://www.benzinga.com/markets/equities/24/09/40965372/fed-delivers-large-interest-rate-cut-in-bid-to-sustain-labor-market-stocks-gold-set-new-record-h">Federal Reserve&#8217;s recent interest rate cut</a> has sparked optimism about potential relief for homebuyers, but industry experts caution against expecting a sharp drop in mortgage rates. According to Chen Zhao, Redfin&#8217;s lead economic analyst, despite the Fed&#8217;s actions, mortgage rates are unlikely to fall below 5.7% in the near term.
Don't Miss:
<ul>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
<li>Beating the market through ethical real estate investing' — t<a href="https://www.benzinga.com/money/invest-with-roots">his platform aims to give tenants equity in the homes they live in while scoring 17.17% average annual returns for investors – here&#8217;s how to join with just $100</a></li>
</ul>
Likewise, Logan Mohtashami, HousingWire&#8217;s lead analyst, predicts that 30-year mortgage rates could settle as low as 5.75% by the end of this year. According to Mortgage News Daily, the average 30-year conforming loan rate currently sits at 6.21%.
The relationship between Fed rate cuts and mortgage rates is more complex than many realize. While the Fed controls the overnight lending rate for banks, mortgage rates are long-term interest rates set by bond markets. Those rates often move in anticipation of Fed actions and can be influenced by various economic factors beyond the central bank&#8217;s direct control.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Two key components determine how Fed actions translate to mortgage rates – the yield curve and the mortgage spread. The yield curve represents the difference between long-term rates like 10-year Treasury yields and short-term rates. The mortgage spread accounts for the additional risk associated with mortgages compared to Treasury bonds.
As the Fed cuts rates, long-term Treasury yields are likely to fall less than short-term rates, potentially resulting in long-term rates being higher than short-term rates, according to Redfin. Simultaneously, the difference between mortgage rates and long-term Treasury yields is expected to decrease. Those factors combined suggest that while mortgage rates may decline, the drop will be much smaller than the Fed Funds rate reduction.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: This investment company boasts a 35.14% internal rate of return (IRR) for its realized projects, allowing accredited investors to<a href="https://www.benzinga.com/money/bam-capital"> earn passive returns and avoid the headaches of being a landlord.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
The labor market&#8217;s strength is another factor in determining how low mortgage rates can go. Kevin Ryan, CFO of Better, noted in an interview with HousingWire that Fed policymakers are more concerned with the labor market than inflation. &#8220;The Fed presumably will continue to stay data-dependent within this recalibration thing,&#8221; Ryan said. &#8220;I see a slowly thawing housing sector. If you wake up in 18 months, you&#8217;re going to have rates materially lower.&#8221;
The recent downward trend in rates has positively impacted the housing market, with <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41024067/mortgage-demand-soars-as-fed-interest-rate-cut-fuels-housing-market-revival-next-sp">purchase applications rising for four consecutive weeks</a>. However, the effect on home sales has been mixed. While new home sales are trending upward, existing home sales continue to struggle, falling 2.5% month-over-month in August, according to the National Association of Realtors.
See Also: This billion-dollar fund has invested in the next big real estate boom,<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> here's how you can join for $10.</a>
Noah Rosenblatt, co-founder of real estate analytics firm UrbanDigs, warns that the housing market has yet to stabilize fully. &#8220;We still have election uncertainty, local policy uncertainty and geopolitical uncertainty that are weighing on investors&#8217; and buyers&#8217; minds and could dampen the depth and duration of this recovery,&#8221; Rosenblatt told HousingWire.
While some relief may be on the horizon for homebuyers, the road to much lower mortgage rates appears longer than many had hoped.
Read Next:
<ul>
<li>If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends<a href="https://www.benzinga.com/money/arrived-private-credit-fund"> would you invest in it</a>?</li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a></li>
</ul>

Real Estate

Why The Fed's Rate Cuts Won't Mean Major Mortgage Relief – Expect 5.7% At Best, According To Industry Leader

Trading Halt: Halted at 8:15:00 a.m. ET - Trading Halt: Halt News Pending

<a href="https://www.globenewswire.com/Tracker?data=jer_jok7qlySMfsyxxA8D0ehdqJLO1vR_-G4UBNMu4BQzZyoF5g6ef018npugG9OKvsSfJJRDi71KVm6mBO5zw==">ResMed</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>, ASX: RMD)))), the world's leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ResMed first in CPAP (continuous positive airway pressure) mask innovation with the launch of the <a href="https://www.globenewswire.com/Tracker?data=vZ8QC91YrRA3qQpiuraELW5mhAtqdLcQAjKw-GEimmzCiY2eA7cApLWQJD0kiSTh9XgKr03qoqq7BiFGyw_WpzbJqY-z00tMlwouwkzvrrgKIv6jt64q9qsTVJ37cqYE">AirTouch&#x2122; N30i</a>. Designed to create a natural and comfortable sleep experience for users, the AirTouch N30i is a fabric-wrapped frame featuring a soft, breathable, and moisture-wicking design for optimal comfort in a tube-up design. &nbsp;
Sleep apnea affects more than 54 million people in the United States and nearly one billion people worldwide1. This chronic sleep-related breathing disorder can impair daily functioning and significantly increase the risk of serious comorbidities such as hypertension, diabetes, cardiovascular disease, and stroke2.

ResMed Enhances CPAP Therapy With Its First Fabric Mask, Designed To Make It Easier For People To Embrace Their Treatment And Improve Overall Sleep Health

Wolfe Research analyst Doug Schenkel downgrades Bruker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) from Outperform to Peer Perform.

Downgrades

BRKR

Wolfe Research Downgrades Bruker to Peer Perform

CleanSpark Offers A Unique Proposition And Is Now Heading To Undervaluation (Rating Upgrade)

Iris Energy (IREN) has released an update. Iris Energy Limited, also known as IREN, has published its consolidated annual financial report and dire...

Iris Energy Leadership Touts Strong Industry Expertise

Iris Energy (IREN) has released an update. Iris Energy Limited has expanded its AI Cloud Services by purchasing 1,080 NVIDIA H200 GPUs, projecting ...

Iris Energy Boosts AI Services and Bitcoin Mining

Iris Energy to increase AI cloud services to 10% of earnings, shares up

Iris Energy to increase AI cloud services to 10% of earnings; IREN shares up

Riot Platforms Offers Asymmetric Upside Potential At Full Capacity

Iris Energy To Benefit From Its AI Cloud Services Expansion

Iris Energy (IREN) has released an update. Iris Energy Limited (IREN) has achieved a significant milestone by increasing its installed capacity to ...

Iris Energy Surpasses Milestone with Expansion Plans

Iris Energy achieves 20 EH/s, on track for 31 EH/s

Iris Energy (IREN – Research Report), the Financial sector company, was revisited by a Wall Street analyst today. Analyst Gautam Chhugani from Bern...

Iris Energy: A Strong Buy on Expansion and Efficiency

BITF

CLSK

CORZ

CORZR

CORZW

CORZZ

CRZWQ

MARA

RIOT

Press Releases

IRIS ENERGY LIMITED ANNOUNCEMENT: If You Have Suffered Losses in Iris Energy Limited (NASDAQ: IREN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

IREN to increase AI Cloud Services to 10% of earnings

Rosen Law Firm Encourages Iris Energy Limited Investors to Inquire About Securities Class Action Investigation - IREN

Legal

IREN achieves 20 EH/s milestone

Amplitude

AvePoint

Blend Labs

Bitdeer Technologies Group - Ordinary Shares

Bitdeer Technologies

Cipher Mining

Sprinklr

E2open Parent Holdings, Inc.Class A Common Stock

E2open Parent Holdings

EverCommerce

Five9

Jamf Holding

Karooooo

MeridianLink

Matterport

NextNav

Opera Limited - American Depositary Shares

Opera

PagerDuty

LiveRamp Holdings

SEMrush Holdings, Inc. Class A Common Stock

SEMrush Hldgs

SoundHound AI, Inc. - Class A Common Stock

SoundHound AI

Sprout Social, Inc - Class A Common Stock

Sprout Social

Tuya Inc. American Depositary Shares, each representing one Class A Ordinary Share

Tuya

Verint Systems

NCR Voyix

Weave Communications

TeraWulf

B. Riley Securities

Cantor Fitzgerald

Compass Point

Canaccord Genuity

Macquarie

수요일 미국 주요 지수는 다우존스 산업평균지수가 0.4% 하락한 41,091.42, S&amp;P 500 지수가 0.6% 하락한 5,592.18로 하락 마감했다. 나스닥지수는 1.1% 하락한 17,556.03에 마감되었다.
이들은 하루 동안 소매 거래자와 투자자들의 주목을 받은 주요 종목들이다:
엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)
이 기술 대기업의 주가는 2.10% 하락하여 $125.61로 마감했으며, 하루 중 최고가와 최저가는 각각 $128.33와 $122.64였다. 특히, 애프터마켓 거래에서 주가가 6.9% 하락하여 $116.95로 떨어졌다. 그럼에도 불구하고, 엔비디아는 강력한 <a href="https://www.benzinga.com/news/earnings/24/08/40613050/nvidia-q2-earnings-guidance-top-street-view-as-ai-fuels-record-data-center-revenue-gross-margin-fal">2분기 실적</a>을 발표했으며, 지난해 같은 기간에 비해 이익과 매출이 두 배 이상 증가했다. 이 회사의 데이터 센터 매출이 전체 매출 상승에 중요한 역할을 했지만, 총 매출 이익률은 1분기 대비 축소되었다.
어펌 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>)
어펌의 주식은 2.86% 하락하여 $31.58로 마감했다. 이 회사는 <a href="https://www.benzinga.com/news/earnings/24/08/40613433/affirm-stock-rallies-after-strong-q4-earnings-upbeat-q1-guidance-what-to-know">강력한 4분기 실적</a>과 긍정적인 1분기 가이던스를 발표했으며, 분기 매출은 $6억 5천 9백만 달러로 지난해 같은 기간 대비 47.82% 증가했다.
크라우드스트라이크 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>)
크라우드스트라이크의 주가는 2.09% 하락하여 $264.2로 마감했다. 이 사이버 보안 회사는 <a href="https://www.benzinga.com/news/earnings/24/08/40613150/crowdstrike-q2-earnings-revenue-beat-eps-beat-arr-up-32-even-more-customer-obsessed-company-followi">2분기 매출</a>이 $963.9 백만 달러로, 컨센서스 추정치를 초과했다고 보고했다.
아이리스 에너지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>)
아이리스 에너지의 주가는 5.60% 하락하여 $7.42로 마감했다. 그럼에도 불구하고, 이 회사는 기록적인 회계 연도 비트코인 (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40614523/iris-energy-stock-climbs-after-fy24-results-4-191-bitcoin-mined-record-mining-revenue-and-">채굴 매출</a>이 $184.1백만 달러에 달했다고 보고했다.
테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
테슬라의 주가는 1.65% 하락하여 $205.75로 마감했다. 오랜 테슬라 투자자이자 거버 가와사키 웰스(Gerber Kawasaki Wealth)의 CEO인 로스 거버(Ross Gerber)가 약 $6천만 상당의 테슬라 주식을 매각하며, 이 <a href="https://www.benzinga.com/markets/equities/24/08/40591876/longtime-tesla-bull-ross-gerber-unloads-60m-in-ev-giants-shares-cites-declining-confidence-nobod">회사의 자동차와 로봇에 대한 관심 부족</a>을 이유로 들었다.
Shutterstock 제공
하루의 거래를 준비하세요 <a href="Premarket Movers &amp; News">주요 프리마켓 동향 및 뉴스</a>를 Benzinga와 함께.
이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>를 사용하여 생성되었으며 <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>에 의해 편집되었습니다.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

아이리스 에너지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>)는 수요일 시장 마감 후에 회계연도 재무 결과를 발표했다. 이 발표로 주가는 시간외 거래에서 5% 이상 상승했다. 다음은 <a href="https://www.benzinga.com/pressreleases/24/08/g40612864/iren-reports-full-year-fy24-results">보고서의 주요 수치</a>들이다.
주요 내용: 아이리스 에너지(Iris Energy)는 운영 해시레이트 증가와 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) ​​가격 상승에 힘입어 회계연도 비트코인 ​​채굴 매출이 지난해 7,550만 달러보다 증가한 1억 8,410만 달러라고 보고했다.
아이리스 에너지는 올해 자체 채굴 용량이 5.6EH/s(초당 약 5.6엑사해시)에서 10EH/s로 증가했다고 보고했다.
<ul>
<li>아이리스 에너지는 주로 운영 해시레이트의 증가에 힘입어 2023회계연도의 3,259비트코인에 비해 기록적인 4,191비트코인을 채굴했다.</li>
<li>AI 클라우드 서비스 매출은 310만 달러였다.</li>
<li>순 전기 비용은 2023회계연도의 3,580만 달러와 비교하여 7,600만 달러였으며, 이는 주로 운영 해시레이트의 증가에 힘입어 해당 연도 동안 80MW의 추가 용량이 시운전되었다.</li>
<li>이 회사는 816개의 엔비디아 H100 GPU로 한 해를 마감하여 여러 고객에게 서비스를 제공했다.</li>
</ul>
아이리스 에너지의 공동 창업자이자 공동 CEO인 다니엘 로버츠(Daniel Roberts)는 "매출, 이익, 현금 흐름 전반에 걸쳐 지속적인 성장을 강조하는 2024 회계연도 전체 결과를 보고하게 되어 기쁘게 생각한다"고 말했다. "우리의 2024년 지침은 변경되지 않았다. 15EH/s를 설치함으로써 다음 달에는 20EH/s, 올해는 30EH/s를 달성할 수 있는 궤도에 올랐다."
전망: 이 회사는 2024년 지침을 변경하지 않고 다음 달에 20EH/s, 올해에는 30EH/s를 달성할 예정이라고 말했다.
IREN 주가 움직임: <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>에 따르면, 아이리스 에너지의 주식은 수요일 애프터마켓에서 5.39% 상승하여 7.82달러에 거래되었다.
이미지: Gerd Altmann from Pixabay
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Iris Energy

뉴스

에 대한 최신 뉴스 Iris Energy (NASDAQ:IREN) 주식

목요일, 8월 29, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌